Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 15:41:32 GMT 2023
by
admin
on
Sat Dec 16 15:41:32 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | HUMAN |
| Source Materials State | ALLOGENIC |
| Source Materials Parent | |
| Part | BLOOD PLASMA |
| Record UNII |
YM6LN8TU2V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB15692
Created by
admin on Sat Dec 16 15:41:32 GMT 2023 , Edited by admin on Sat Dec 16 15:41:32 GMT 2023
|
PRIMARY | |||
|
300000020311
Created by
admin on Sat Dec 16 15:41:32 GMT 2023 , Edited by admin on Sat Dec 16 15:41:32 GMT 2023
|
PRIMARY | |||
|
YM6LN8TU2V
Created by
admin on Sat Dec 16 15:41:32 GMT 2023 , Edited by admin on Sat Dec 16 15:41:32 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| TARGETED ANTIGEN | IMMUNOLOGICAL | SARS-COV2 | B6L4N5Z4GH |